Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Chronic Chagas Disease
NCT04984616Phase 2Terminated
- Start
- Oct 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in American trypanosomiasis (CD). Started Oct 2021; status: terminated.
02
Drugs
atorvastatin
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on NCT04984616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04984616.